| NUFORMIX PLC LS -,0005 |
| Großbritannien |
| Gesundheit |
| GB00BYW79Y38 / A141LG |
| 1RT (Frankfurt) |
| FRA:1RT, ETR:1RT, 1RT:GR |
| - |
| https://nuformix.com/ |
|
Nuformix Plc is a pharmaceutical company that focuses on the development of cocrystal technology for novel outcomes in drug efficacy and delivery. The company's primary function is to utilize its expertise in pharmaceutical cocrystal intellectual pro..
>Volltext.. |
| 5.38 Mio. EUR |
| 5.27 Mio. EUR |
| - |
| -0.74 Mio. EUR |
| -0.76 Mio. EUR |
| - |
| - |
| 0.11 Mio. EUR |
| -0.72 Mio. EUR |
| 0.37 |
| - |
| 82.91% |
| - |
| - |
| - |
| - |
| NUFORMIX |
| 05.04.26 |
|
||||
|
||||
|